Barcelona will bring together leading international experts in research and clinical practice in neurodegenerative diseases, in a program designed to address the key challenges of Alzheimer’s.
Among the highlights: — Biomarkers and PET: early diagnosis and monitoring — Neuroinflammation: new therapeutic targets — New Treatment Strategies and Disease-Modifying Treatments: emerging therapies — AI (Artificial Intelligence): improving diagnosis — Neuropathology: understanding the disease — Social Value of Treatment: impact on patients and healthcare systems
A multidisciplinary approach connecting research, clinical practice, and real-world impact.
On-site places are limited, and the strong interest in the event confirms its relevance within the scientific community. Taking part in this conference means accessing cutting-edge knowledge and joining the conversations shaping the future of Alzheimer’s.
Be part of the meeting. 🎟️ Final spots available here.
